Tweet
Financial Express |
Merck immunotherapy drug shows promise in bladder cancer Reuters MADRID (Reuters) - Merck & Co's new immune system drug Keytruda has produced encouraging results in early tests against bladder cancer, according to a company-sponsored study, prompting the firm to prepare a clinical trial later this year. Keytruda is the ... Merck: KEYTRUDA Achieves 24% Response Rate In PD-L1 Positive Urothelial ...NASDAQ MSD Announces First Presentation of Early Data on the Investigational Use of ...Business Wire (press release) Merck Reports Results Of KEYTRUDA In Patients With Advanced Stomach CancerRTT News Daily Mail all 42 news articles » |
More...